Iren Limited's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Iren Limited (IREN) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: Iren Limited vs Its Competitors
- TTM: Trailing 12-month revenue of 1,206M vs 3M combined for tracked competitors (99.8% combined share).
- Trending: Latest-quarter revenue run-rate is decelerating (-54.5% annualized vs trailing 12 months), vs accelerating (+85.0%) for its tracked peer group.
- Growth: Iren Limited generated -26.7% revenue growth year over year in Q4 2026, vs 154.5% for its tracked competitors combined.
- Profitability: Its -498.5% net margin compares with -388.8% for the peer group.
- Scale: Iren Limited ranks #11 of 117 companies by market capitalization in the Miscellaneous Financial Services industry, holding 2.1% of industry market cap.
- Peer revenue share: Iren Limited accounted for 99.1% of combined revenue among its tracked peer group, down from 99.7% a year earlier.
- Peer differentiation: Revenue per employee of $1.76M compares with $0.28M for the peer group (6.3x).
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
IREN Sales vs. its Competitors, Q4 2026
Iren Limited reported revenue contraction of 26.73 % year on year in Q4 2026, below its competitors' combined revenue growth of 154.50 %.
With a net margin of -498.45 %, Iren Limited reported lower profitability than its competitors (-388.81 %).
Iren Limited generated 99.07 % of the combined sales of its peer group, down from 99.73 % a year earlier.
Iren Limited vs. its Competitors, Q4 2026
Revenue growth, year on year
Net margin
Revenue run-rate vs trailing 12 months
TTM net margin
TTM = trailing twelve months. Run-rate annualizes the latest quarter (×4) and compares it to TTM. In millions of $. High-Confidence Competitors are named as a competitor directly in an SEC filing; Similar-Size Competitors are the closest peers by market-cap rank within the same industry; Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC, all independent of the competitor list.
TTM revenue, latest-quarter run-rate and net income/margin benchmarked across Iren Limited and its 4 competitor groupings. Available under Commercial License.
| Entity | TTM Revenue | Rev Run-rate vs TTM |
|---|---|---|
| Iren Limited | $12,345M | +12.3% · Accelerating |
| Competitors combined | $12,345M | +12.3% · Accelerating |
| High-Confidence Competitors (6) | $12,345M | +12.3% · Accelerating |
| Similar-Size Competitors (8) | $12,345M | +12.3% · Accelerating |
TTM revenue, run-rate and net margin benchmarking across Iren Limited's competitor groups requires a Commercial License.
For context: the Miscellaneous Financial Services industry grew revenue 293.3% year over year, combined, vs -26.7% for Iren Limited. Iren Limited's share of combined industry revenue moved from 0.22% to 0.04%, a loss of 0.18 percentage points.
Iren Limited's Competitor Quality Breadth
Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| Iren Limited | No | - | - | No |
| Competitors combined (2) | ||||
| High-Confidence Competitors (10) | ||||
| Similar-Size Competitors (10) |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.
IREN Stock Performance relative to its Competitors
IREN Stock Performance relative to High-Confidence Competitors
IREN Stock Performance relative to Similar-Size Competitors
5 Best-Performing Tracked Competitors, Trailing 12 Months
| # | Competitor | TTM Share Price Return | vs U.S.A. 500 |
|---|---|---|---|
| 1 | Power Reit | 282.9% | Outperformed |
| 2 | Aldeyra Therapeutics Inc | 282.9% | Outperformed |
TTM share price return and U.S.A. 500 outperformance for Iren Limited's best-performing tracked competitors requires a Commercial License.
Source: CSIMarket API, trailing 12 months.
Iren Limited's Comment on Competition and Industry Peers
Publicly Traded Peers of Iren Limited
Revenue and income for trailing 12 months, in millions of $, except employees| Company | Market Cap | Revenues |
|---|---|---|
| Iren Limited | 13,188.66 | 1,205.67 |
| Aldeyra Therapeutics Inc | 69.97 | - |
| Power Reit | 2.53 | 2.79 |
| SUBTOTAL | 13,261.16 | 1,208.46 |
Sources: Iren Limited's official press releases and regulatory filings; CSIMarket.com's market research; and the financial filings and press releases of the other companies cited.
Updated on:
Focus of this report: publicly traded companies. Ten additional tables on Iren Limited versus competitors, including market share analysis, are in the navigation menu under Competition. To download the tables, please subscribe.
Iren Limited's Competitors Named by the Company
Competitive relationships identified from SEC filings and corroborating sources, each with a basis and confidence.| Competitor | Basis | Confidence |
|---|---|---|
| Iris Energy | Named by the company | 85% |
| CoreWeave | Named by the company | 85% |
| Nebius | Named by the company | 85% |
| Cipher Digital Inc | Named by the company | 85% |
| Lambda | Named by the company | 85% |
| SpaceX | Named by the company | 85% |
| Sharonai Holdings Inc | Named by the company | 85% |
| Crusoe | Named by the company | 85% |
| Nscale | Named by the company | 85% |
| Hyperscale Data Inc | Named by the company | 85% |
| Amazon Web Services | Named by the company | 85% |
| Microsoft Azure | Named by the company | 85% |
| Soluna Holdings Inc | Named by the company | 85% |
| Google Cloud | Named by the company | 85% |
| Oracle Cloud | Named by the company | 85% |
| Power Reit | Named by the company | 85% |
Filing basis, confidence, active dates and source counts for Iren Limited's named competitors require a Commercial License.
Methodology: relationships are extracted from SEC filings (named-competitor disclosures) and corroborating sources. Named by the company = explicitly disclosed as a competitor; Inferred = derived from corroborating signals. Confidence reflects evidence strength.
Iren Limited's Business Segment Mix vs Peers
Revenue by operating segment or division, as named and reported by each company. Segment names are the filer's own and are not standardized across companies. Do not assume a same-named or similarly-named segment is defined identically between two companies. Shares are of each company's own total revenue and are not required to sum to 100% (intersegment revenue, unallocated items).| Company | Largest Segment |
|---|---|
| Iren Limited | Bitcoin Mining Revenue 89.36 % |
Source: operating segment revenue as reported in each company's SEC filings (10-K/10-Q), via the CSIMarket API, leaf-level reportable segments only (parent roll-up segments are excluded where sub-segments are separately disclosed).
Iren Limited's Productivity vs Peers Comparison
Revenue and income per employee, trailing 12 months, in $; market cap in millions of $| Company | Market Cap | Revenue / Employee | Income / Employee |
|---|---|---|---|
| Iren Limited | 13,189 | 1,760,105 | -1,025,724 |
| Aldeyra Therapeutics Inc | 70 | - | -2,881,593 |
| Power Reit | 3 | 1,394,696 | -780,303 |
| PEERS TOTAL | 73 | 278,939 | -2,461,335 |
Iren Limited's Position in Industry Market Structure
Market-capitalization share and concentration across all 103 companies in Iren Limited's industry classification, broader than the peer set above. Market cap in millions of $.Iren Limited ranks #11 of 103 companies by market capitalization in its industry, holding 2.10 % of total industry market cap. The industry's Herfindahl-Hirschman Index (HHI) is 1,294, indicating a unconcentrated market structure (U.S. antitrust guidance: below 1,500 unconcentrated, 1,500 to 2,500 moderately concentrated, above 2,500 highly concentrated).
| Rank | Company | Market Cap | Industry Share |
|---|---|---|---|
| 1 | American Express Company | 207,244 | 31.55 % |
| 2 | Nu Holdings Ltd | 61,219 | 9.32 % |
| 3 | Coinbase Global Inc | 51,945 | 7.91 % |
| 4 | Eason Technology Limited | 38,113 | 5.80 % |
| 5 | Strategy Inc | 1,234 | 5.2% |
| 6 | Federal National Mortgage Association Fannie Mae | 1,234 | 5.2% |
| 7 | Synchrony Financial | 1,234 | 5.2% |
| 8 | Circle Internet Group Inc | 1,234 | 5.2% |
| 9 | Sofi Technologies Inc | 1,234 | 5.2% |
| 10 | Bitmine Immersion Technologies Inc | 1,234 | 5.2% |
| 11 | Iren Limited | 13,789 | 2.10 % |
Market cap and industry share for the rest of Iren Limited's industry peers requires a Commercial License.
Source: CSIMarket API (daily market-structure computation) across CSIMarket's industry classification, market capitalization as of 2026-09-28.
Iren Limited's Same-Size Peers & Stock Performance
Peers chosen by closeness in market-cap rank within the same industry classification (not the named-competitor list above). Trailing 12-month total return, 3-month price momentum, beta and Sharpe ratio vs the broad U.S. market.| Rank | Company | Market Cap | TTM Return |
|---|---|---|---|
| 6 | Federal National Mortgage Association Fannie Mae | 27,992 | -62.66 % |
| 7 | Synchrony Financial | 23,962 | -3.45 % |
| 8 | Circle Internet Group Inc | 23,240 | -30.60 % |
| 9 | Sofi Technologies Inc | 21,966 | -42.22 % |
| 10 | Bitmine Immersion Technologies Inc | 1,234 | 12.3% |
| 11 | Iren Limited | 13,789 | -5.77 % |
| 12 | Federal Home Loan Mortgage Corporation | 1,234 | 12.3% |
| 13 | Hut 8 Corp | 1,234 | 12.3% |
| 14 | Chime Financial Inc | 1,234 | 12.3% |
| 15 | The9 Ltd | 1,234 | 12.3% |
| 16 | Riot Platforms Inc | 1,234 | 12.3% |
Market cap, return, momentum, beta and Sharpe ratio for the rest of Iren Limited's same-size peers requires a Commercial License.
Source: CSIMarket API (daily market-structure computation); returns and risk metrics as of 2026-09-28. Beta and Sharpe ratio are versus the broad U.S. equity market, not this industry.
Iren Limited's Profitability & Cost Structure
Trailing 12-month margins from SEC-filed financials. Operating margin is compared to the Miscellaneous Financial Services industry median; gross margin, EBITDA margin and capital intensity are compared to the live industry average (80 companies).| Metric | Company | Industry | Difference |
|---|---|---|---|
| Gross Margin | 70.62 % | 53.42 % (avg) | +17.2 pp |
| Operating Margin | -86.82 % | industry median | -72.3 pp |
| EBITDA Margin | -21.30 % | 2.15 % (avg) | -23.4 pp |
| Capital Intensity (Capex / Revenue) | 257.58 % | 4.86 % (avg) | +252.7 pp |
Source: CSIMarket API, trailing 12 months. SG&A and R&D as a share of revenue have limited coverage as this data is backfilled and appear only where reported. Higher capital intensity is not inherently negative; it reflects the industry's asset requirements.
Iren Limited's Valuation vs Competitive Position
Valuation multiples vs the Miscellaneous Financial Services industry average (80 companies, excluding loss-making/negative-equity outliers), alongside returns on capital for context on whether a premium or discount lines up with measurably stronger or weaker returns.| Metric | Company | Industry Average | Difference |
|---|---|---|---|
| P/E | - | 18.8x | - |
| EV / EBITDA | - | 15.3x | - |
| P/B | 5.5x | 3.1x | +2.4x |
| Return on Equity | -24.35 % | industry aggregate | -17.46 % |
| Return on Invested Capital | -10.71 % | 0.51 % (avg) | -11.22 % |
Source: CSIMarket API, trailing 12 months. A valuation premium or discount is not, by itself, a judgment of over- or under-valuation. Compare it against the return and growth context shown elsewhere on this page.
Iren Limited's BCG Growth-Share Matrix
Relative market share (vs Iren Limited's largest competitor by market cap) against industry revenue growth, using the standard textbook thresholds (1.0x share, 10% growth) a common framework, not a precision instrument.
Iren Limited falls in the Dog quadrant: relative market share of 0.07x vs its largest competitor, in an industry growing revenue 3.4% (median, trailing 12 months).
Source: CSIMarket API (market-cap share and industry revenue growth). The 10% growth and 1.0x share lines are standard textbook thresholds, not derived from this industry's own distribution.
Iren Limited's Competitive Forces (Porter's Five Forces)
Only the forces this data can support honestly are shown; the other three are marked as such rather than guessed.| Force | Assessment | Basis |
|---|---|---|
| Competitive Rivalry | High | Industry HHI of 1,294 (see Industry Market Structure & Concentration above) |
| Barriers to Entry | High (capital intensive) | Capital intensity (capex / revenue) of 257.58 % vs industry average 4.86 % (see Profitability & Cost Structure above) |
| Supplier Power | Not covered on this page | See Iren Limited's dedicated suppliers page for concentration and dependency data |
| Buyer Power | Not covered on this page | See Iren Limited's dedicated customers page for concentration and dependency data |
| Threat of Substitutes | - | No systematic data source for cross-product substitution exists in this system; not estimated |
Note: this is a partial, data-grounded application of the framework, not a complete strategic assessment. Rivalry and barriers-to-entry readings are mechanical translations of the HHI and capital-intensity figures shown elsewhere on this page, not independent judgments.
Iren Limited's Industry Attractiveness & Competitive Strength
A CSIMarket composite, not a standard field: each axis is an equal-weighted average of three factors already shown elsewhere on this page (industry growth, industry profitability and rivalry for attractiveness; relative market share, profitability and growth vs industry for strength). Disclosed as a designed methodology, not a precision measurement.
Iren Limited falls in the Low attractiveness / Low strength cell: Harvest / Divest.
Source: CSIMarket API, trailing 12 months. Each axis score is a simple 1(low)/2(medium)/3(high) average across its three inputs -- a transparent, disclosed simplification, not a validated academic scoring model.
Iren Limited's SWOT
Every point below is a fixed rule applied to a metric already shown elsewhere on this page (Market Structure, Profitability, Valuation, Run-Rate, Stock Performance, Quality Breadth) not an independent strategic assessment. A blank quadrant means no rule was met, not that none apply.Strengths
No rule matched.
Weaknesses
- Operating margin 72.3 points below the industry median.
- Return on equity 17.5 points below the industry aggregate.
- Latest-quarter revenue run-rate is decelerating (-54.5% annualized vs trailing 12 months).
- Underperforming the U.S.A. 500 over the trailing 12 months.
- Low relative market share vs the industry leader (0.07x).
Opportunities
No rule matched.
Threats
- High capital intensity requires continuous reinvestment just to keep pace with the industry.
Methodology: mechanical, rule-based SWOT. Each bullet reuses a figure already sourced and cited elsewhere on this page; nothing here is generated narrative or independent analyst judgment.
Iren Limited's Financial Strength vs Peers Comparison
Quick ratio, working capital, debt to equity and asset turnover, trailing 12 months| Company | Quick Ratio | Working Capital | Debt / Equity |
|---|---|---|---|
| Iren Limited | 1.80 | 2.24 | 1.16 |
| Aldeyra Therapeutics Inc | - | 2.91 | 0.26 |
| Power Reit | 1.98 | 1.98 | 3.96 |
Quick ratio = cash / current liabilities; working capital ratio = current assets / current liabilities; asset turnover = revenue / total assets. Peers in the Blank Checks industry are excluded.
Iren Limited's Revenue and Income Growth vs Peers
Quarterly revenue and net income growth, year over year and quarter over quarter| Company | Period | Revenue Y/Y | Income Y/Y |
|---|---|---|---|
| Iren Limited | Q2 2026 | -26.7 % | - |
| Aldeyra Therapeutics Inc | Q2 2026 | - | - |
| Power Reit | Q2 2026 | +154.5 % | +35.7 % |
| PEERS TOTAL | -26.2 % | - |
Growth is shown only where both periods are positive. Peers in the Blank Checks industry are excluded.
Iren Limited's Peers' Costs of Sales and Capital Expenditures
Context for revenue growth: peer costs and capex, year over year and quarter over quarter| Company | Period | Costs Y/Y | Capex Y/Y |
|---|---|---|---|
| Iren Limited | Q2 2026 | - | +621.8 % |
| Aldeyra Therapeutics Inc | Q2 2026 | - | - |
| Power Reit | Q2 2026 | - | - |
Iren Limited's Returns and Turnover vs Peers
ROA, ROI and ROE (trailing 12 months), receivables and inventory turnover| Company | ROA | ROI | ROE |
|---|---|---|---|
| Iren Limited | - | - | - |
| Aldeyra Therapeutics Inc | - | - | - |
| Power Reit | - | - | - |
ROA = net income / total assets; ROI = net income / investments; ROE = net income / equity; turnover ratios use trailing 12 month revenue (receivables) and cost of sales (inventory).
Iren Limited's Valuation vs Peers
P/E, price to sales, PEG, price to cash flow and price to book| Company | P/E | Price / Sales |
|---|---|---|
| Iren Limited | - | 10.94 |
| Aldeyra Therapeutics Inc | - | - |
| Power Reit | - | 0.91 |
| PEERS AVERAGE | - | 10.97 |
P/E = price / diluted EPS (trailing 12 months); PEG = P/E divided by EPS growth; the average row divides the peers' combined market cap by their combined income, sales, cash flow and equity.